Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae.
Sato
K
K
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000494:pharmacology; D004341:Drug Evaluation; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000494:pharmacology; D018942:Macrolides / Q000494:pharmacology*; D008911:Minocycline / Q000494:pharmacology*; D009177:Mycoplasma pneumoniae / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology; D015363:Quinolones / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D018942:Macrolides; D010879:Piperazines; D015363:Quinolones; D008911:Minocycline; C075375:grepafloxacin